Introduction
Myocardial fibrosis is characterized by an accumulation of extracellular matrix in the myocardium and is an integral component of most myocardial diseases. In normal myocardium, the extracellular matrix provides a structural basis and protects against myocardial rupture.
An excessive accumulation of fibrosis, however, affects both the structural integrity of the cardiac muscle and the electrical conductive properties of the myocardium. [1] [2] [3] Myocardial fibrosis can be distinguished at the macroscopic (replacement or focal myocardial fibrosis) or at the microscopic level (reactive or infiltrative interstitial fibrosis) by pathology and cardiac magnetic resonance (CMR). Even though this dichotomy is only a rough classification of observed fibrosis patterns, it allows for the evaluation of different pathogenic patterns. CMR provides a non-invasive phenotyping tool for accurate and easy detection and quantification of myocardial fibrosis by probing the retention of gadolinium-contrast agent in myocardial tissue. Late-gadolinium enhancement (LGE) magnetic resonance imaging (MRI) has been used extensively in a large number of studies for measurement of myocardial scarring. 4, 5 T1 mapping provides a direct measurement of the extracellular volume (ECV) fraction of the myocardium, and has demonstrated the ability to measure diffuse myocardial fibrosis that LGE is incapable of measuring. 6 While replacement fibrosis associated with tissue necrosis is likely found in those with prior cardiovascular disease (CVD), whether diffuse fibrosis is also increased is unknown. The association of fibrosis with prior cardiovascular (CV) events independent of the risk factors may be indicative of the role of inflammation, thrombosis and other pathologic pathways. While increased diffuse fibrosis has been associated with future events, the study of the effect of prior events is important to help understand the different pathways leading to diffuse interstitial fibrosis. In this retrospective study, we used contrastenhanced MRI to evaluate the association between CVD in MESA ascertained over 10 years with both myocardial replacement and interstitial fibrosis measured at year-10.
Methods Population
The multi-ethnic study of atherosclerosis (MESA) is a prospective, population-based observational cohort study of 6814 men and women representing four racial/ethnic groups, aged 45-84 years and free of clinical CV disease at enrolment. 7 A total of 3015 participants underwent a follow-up CMR (with 29 excluded for insufficient image quality) between 2010 and 2012, 10 years after the baseline examination. 8 Participants undergoing CMR scans were screened for gadolinium (Gd) eligibility. Participants with glomerular filtration rate (GFR) > _45 mL/min (60 mL/ min for one field centre) and without history of allergic reaction to contrast agents were qualified to receive Gd. Of the eligible participants, 1840 agreed to a Gd injection, and underwent LGE imaging. A total of 1345 participants who received Gd infusion also had T1 mapping as part of the protocol (one field centre did not have the necessary sequence). The institutional review boards of all field centres approved the study protocol and all participants gave informed consent. MESA is an observational cohort that has been studied before and over 1400 articles have been published with MESA data. However, only a few prior studies have utilized the participants listed here with the aforementioned T1 and/or myocardial scar data. Prior articles have explored in the same population (1840 participants), the association of fibrosis with ageing, 9 identifying correlates of myocardial scar, 10 association of fibrosis with ventricular 2,11 and atrial 12 remodelling, and the association with electrocardiographic parameters. 13 However, our study is unique in trying to identify the association between CV events and myocardial fibrosis, introducing a formula for estimation of haematocrit (and consequently ECV) from T1 images without the need for a blood draw based on a large multicentre sample, and elucidating the association of CV risk factors with diffuse myocardial fibrosis.
Assessment of risk factors
Conventional risk factor measures (age, race, gender; body mass index, smoking status, systolic blood pressure, use of hypertension medication, diabetes mellitus/impaired fasting glucose, LDL cholesterol, total cholesterol), 14 and coronary calcium scores 15, 16 were obtained as explained previously. These risk factors were obtained at baseline as well as at the follow-up exam.
Outcomes
In addition to MESA follow-up examinations, a telephone interviewer contacted each participant (or representative) every 6-9 months to inquire about all interim hospital admissions, CV outpatient diagnoses, and deaths. Two physicians reviewed all records for independent end-point classification and assignment of event dates. The all CV events endpoint included coronary heart disease (CHD), peripheral vascular disease (PAD), stroke, heart failure (HF), and atrial fibrillation (AF). Criteria for CHD outcomes included any of-myocardial infarction (MI), resuscitated cardiac arrest, definite angina, and probable angina (if followed by revascularization 
CMR imaging
MESA participants underwent CMR exams using 1.5 T scanners (Avanto and Espree, Siemens Medical Systems; Signa LX, GE Healthcare) with a six-channel anterior phased-array torso coil and corresponding posterior coil elements.
LGE-CMR images were obtained 15 min after an intravenous bolus injection of gadolinium-diethylene triamine penta-acetic acid (0.15 mmol/kg, Magnevist, Bayer Healthcare Pharmaceuticals, NJ, USA) to identify replacement fibrosis. 17 Ten to 12 short-axis slices covering the entire left ventricle, one horizontal and one vertical long axis images were acquired. The images were analysed using QMass (Medis, Leiden University Medical Center, Leiden, Netherlands) using the Full-Width-atHalf-Maximum method. 18 Ischaemic pattern was defined as any hyperenhancement area involving the subendocardium or transmural, and also located in a region that is consistent with the perfusion territory of an epicardial coronary artery. 19 Hyperenhanced areas that didn't fit the ischaemic criteria were defined as non-ischaemic. Figure 1 shows LGE-CMR images from a MESA participant with scar. Mid LV short-axis T1 maps were acquired pre-and post-contrast injection using the modified look-locker imaging (MOLLI) sequence. 20 Images were analysed with QMass (Research version, Leiden, Netherlands). On each T1-map (pre-and post-contrast), a region of interest was manually drawn around the core myocardium to calculate the myocardial T1 time. This segmentation included areas of myocardial scar, when present. Lower post-contrast T1 times have been associated with greater diffuse myocardial fibrosis. 6, 21 Partition coefficient was determined by plotting the 1/T1 times of myocardium against the blood pool and calculating the slope of resultant linear regression line. Extracellular volume fraction (ECV) was calculated by ECV = Partition Coefficient*(1-haematocrit/ 100). chamber view and one two-chamber view were acquired as described previously. 22 LV structural parameters (LV mass and volumes) and LV ejection fraction were measured using commercially available software (CIM v6.2, Auckland, New Zealand). 23 
ECV quantification
In the study population, haematocrit was measured in only 681 of the total 1345 participants with T1 mapping. Hence ECV was calculated in 681 participants. Recently, Treibel et al. 24 introduced a method of calculating ECV without measurement of haematocrit. This method was based on observations that haematocrit was correlated with precontrast T1 values of the blood pool. We used similar methodology where we performed an errors-in-variables linear regression between haematocrit as the dependent variable and pre-contrast T1 of the blood pool as the independent variable. A reliability of 0.79 was assumed based on a prior publication that reported the pre-contrast T1 variability using MOLLI. The synthetic haematocrit values were calculated as HCTsyn = 726.19*(1/T1 precontrast blood ) -0.07. These synthetic haematocrit values were then used for measurement of ECV (sECV). The sECV and ECV were highly correlated (ICC = 0.89) and the difference between the two was not significant (mean difference = 0.017%, standard deviation = 1.435, P = 0.75). Figure 3 shows the correlation plot and the Bland-Altman plot of comparison between sECV and ECV in the 681 participants. On the basis of these results, synthetic ECV was calculated for all participants.
Statistical analysis
Statistical analysis was performed with STATA, version 12 (Stata Corp, TX, USA). Cross-sectional analysis assessed the relationship of the composite CV event to each of the focal (presence/absence of myocardial scar by LGE) and diffuse myocardial fibrosis (pre-contrast T1, post-contrast T1 at 12 and 25 min, ECV, and synthetic ECV) indices Association of myocardial fibrosis and cardiovascular events separately adjusted for demographics (age, gender, race), traditional CV risk factors (hypertension, dyslipidaemia, diabetes, body mass index, pack-years of smoking, and flomerular filtration rate) using logistic (for presence/absence of scar as dependent variable) and linear (T1 times and ECV as dependent variables) multivariable regression models. Additional analysis was performed to assess associations of diffuse fibrosis with events after adjustment for the presence of any myocardial scar on the same slice as the T1 mapping slice. P < 0.05 was used for determining statistical significance.
Results
Of the 1840 participants included, 156 had prior CVD events (69 CHD, 16 HF, 40 AF, 40 stroke, and 18 PAD) adjudicated as part of MESA after the baseline exam. The mean age of participants at the Year 10 exam was 68 ± 9 years. Participants with prior CVD events were older, more likely to be male, and Caucasian and less likely to be Chinese-American. The proportion of diabetic and/or hypertensive individuals was also higher among those with prior events when compared with the overall population. Participants with a history of CVD events also had a higher LV mass (by more than 5 g/m 2 ), higher LV mass-to-volume ratio (higher by $0.08 g/mL) and lower ejection fraction (by approximately 3%) than event-free participants. Participants with events also had higher coronary artery calcium score (43% with calcium score >100 when compared with 15% in those with no events) and Framingham 10 year CVD risk score (by more than five points). These differences in MRI measures of structure and function, as well as coronary artery calcium score remained significant after adjustment for participant age. Supplementary data online, Table S1 provides the participant characteristics measured at baseline (between 2000 and 2002), before the occurrence of any CVD events. Table 1 shows the association of markers of myocardial fibrosis with CV risk factors. The presence of a myocardial scar was associated with age, male gender, Caucasian or African-American ethnicity, and hypertension at the time of the exam. Age and female gender were directly associated with higher diffuse interstitial fibrosis. There was an interaction between the age and gender terms, indicative of a greater increase of diffuse fibrosis with age in men when compared with women. Caucasian, African-American, and Hispanic ethnicity was associated with greater diffuse interstitial fibrosis as assessed by lower post-contrast T1 times. Participants with impaired fasting glucose and untreated diabetes had greater diffuse fibrosis as assessed by lower post-contrast T1 times. Increased body mass index (BMI) was associated with lower post-contrast T1 times in participants with treated diabetes or those without diabetes but not in those with untreated diabetes (interaction term of Diabetes status Â BMI was significant). ECV was not associated with diabetes and inversely associated with BMI. Hypertension at the time of the exam was not associated with markers of diffuse fibrosis. Dyslipidaemia was associated with lower post-contrast T1 times. Pack-years of smoking was strongly associated with higher ECV and weakly associated with lower post-contrast T1 times in the multivariable model (P = 0.09). GFR was associated with both post-contrast T1 at 12 min and 25 min but not with ECV or pre-contrast T1 times. When the association of risk factors was studied, after excluding particpants with prior CV events or those with focal scarring, the associations remained largely the same (see Supplementary data online, Table S3 ).
Myocardial fibrosis and cardiovascular risk factors

Myocardial fibrosis and prior cardiovascular events
The proportion of participants with myocardial scar was significantly higher in those with prior CHD (47%), HF (37.5%), and stroke (20%) when compared with those with no prior events (6.2%) (see Table 2 ) (and Supplementary data online, Table S2 ). However, the associations between presence of myocardial scar with AF and PAD were not statistically significant. In logistic regression analysis, the presence of LGE was strongly associated with prior CV events even after adjustment for risk factors (see Table 3 ). Furthermore, ischaemic but not non-ischaemic scars, were associated with a history of CV events. This relationship remained after adjustment for CV risk factors. However, ischaemic scars (8.8 ± 7.9%) were considerably larger (P < 0.001) than non-ischaemic scars (2.9 ± 4.6%) when characterized as percent of the total myocardial mass. LV scar size was independently associated with CV events after adjustment for risk factors ( Table 3) .
Pre-contrast T1 times were not significantly different between the participants with and without a history of CV events ( Table 2 ). In general, participants with CVD events had a lower post-contrast T1 time (by about 10-20 ms for both post-contrast T1 at 12 min and 25 min after contrast injection) and higher ECV (by approximately 1.6-2%) values, both indicative of greater diffuse myocardial fibrosis when compared with the participants who did not have prior events. The final linear regression results are tabulated in Table 3 for all CV events. The association between diffuse myocardial fibrosis (as assessed by post-contrast T1 times and ECV) and prior composite CV events remained significant after adjustment for CV risk factors and demographics ( Table 3) . The relationships between postcontrast T1/ECV and events were slightly attenuated when those who had myocardial scar on the same slice as the T1 mapping slice were excluded (n = 39; T1 at 12': coeff = -6.0 ms, P = 0.11; T1 at 25': coeff = -6.6 ms, P = 0.08; sECV: coeff = 0.91%, P = 0.002). When participants with myocardial scar anywhere in the myocardium were exluded, the relationships were not significant for post-contrast T1 times but remained significant for ECV (Model 3 in Table 3 ).
Discussion
In this retrospective study, we show that in a multi-ethnic free living population, having a CV event during the prior 10 years was associated with both a higher likelihood of ischaemic myocardial scar on late gadolinium enhancement imaging, as well as increased diffuse interstitial fibrosis assessed by T1 mapping.
Ischaemic myocardial scars are associated with tissue necrosis after MI, but also with myocardial damage associated with non-ischaemic cardiomyopathies where repeated toxic insults may result in cellular apoptosis and localized formation of collagenous scars. 25 Pre-contrast T1 is a measure of both intracellular and extracellular space and, therefore, can be less sensitive to increased ECV or more sensitive to other characteristics of the tissue. Indeed, this might be the case in our study where pre-contrast T1 times were unrelated to AF, atrial fibrillation; All cardiovascular, CHD þ HF þ AF þ stroke þ PAD; CHD, coronary heart disease; HF, heart failure; PAD, peripheral arterial disease. history of CVD. This is in contrast to other studies where native T1 has proven useful in several disease conditions.
30-34
Post-contrast T1 and ECV allow for the quantification of diffuse fibrosis based on the amount of gadolinium contrast in the extracellular space. 35 Post-contrast T1 and ECV were significantly associated with CV events, indicating greater diffuse fibrosis in participants who had CV events over the 10-year follow-up in our study. Several mechanisms may be at play for the associations observed in this study. Disruption of the equilibrium between myocyte death and regeneration by comorbidities of atherosclerosis, AF, and HF may be associated with acceleration of age-related extracellular fibrotic remodelling. 22 The effect of long-standing hypertension, 11 age and gender 9 on diffuse interstitial fibrosis has been previously studied. Here, we also show that diffuse interstitial fibrosis is related to impaired fasting glucose, untreated diabetes, dyslipidaemia, and pack-years of smoking. These associations were after adjustment for age and gender, which are associated with myocardial interstitial fibrosis as well. The association of fibrosis with CV events independent of the risk factors may be indicative of the role of inflammation, thrombosis and other pathologic pathways.
Sibley et al. 21 showed that a 20 ms lower post-contrast T1 time was associated with 1.5-2% higher degree of myocardial fibrosis by histology. Mascherbauer et al. 36 showed in patients with HF with preserved ejection fraction that those who went on to have cardiac events had a 40 ms lower post-contrast T1 time when compared with those without events. Wong et al. 37, 38 showed in patients referred for cardiac MRI, that every 3% higher value of ECV was associated with $50% higher likelihood of mortality and/or hospitalization for HF. Kammerlander et al. 39 and Ghosn et al., 40 similarly, showed in CMR referred patients that a 1% higher ECV was associated with approximately 10% likelihood of hospitalization or cardiac death. In our study, those with prior CVD events had a 1.5-2% higher ECV and/or a 10-15 ms lower post-contrast T1 time. Therefore, even small changes in diffuse fibrosis could potentially be an important marker of myocardial health. Furthermore, in our study, while the proportion of participants with a myocardial scar was not different between those who did not have any events and those with a history of AF, those with AF had a higher ECV indicative of greater diffuse fibrosis (see Supplementary data online, Table S2 ). This finding is particularly interesting in the context that lower post-contrast T1 times have been associated with lesser LA function, 12 and higher ECV has been proposed as a marker of recurrent AF in patients with prior hypertension and AF. 41 Several mechanisms may be at play for the associations observed in this study. 42, 43 Myocardial scar on LGE can occur as a direct result of myocyte necrosis after acute MI. Myocyte death triggers the activation of cardiac fibroblasts, leading to an inflammatory response that governs myocardial collagen turnover. This acute inflammation after a cardiac event may also be at play in increased deposition of diffuse interstitial fibrosis as observed on T1 maps. 44, 45 Disruption of the equilibrium between myocyte death and regeneration by conditions such as hypertension, pressure and volume overload events, diabetes, obesity, and chronic inflammatory processes-all associated with atherosclerosis (CHD, PAD and stroke), AF, and HF may also be responsible for acceleration of age-related extracellular fibrotic remodelling. 22 Indeed, in our study, the participants who had a history of CV events, were older and had a greater burden of atherosclerosis as assessed by coronary artery calcium and Framingham risk scores (both after and before the occurrence of the events- Table 4 and Supplementary data online, Table S1 ), perhaps reflecting increased incidence of plaque rupture and small vessel microembolization leading to focal myocardial scars and increased diffuse interstitial fibrosis. Increased haemodynamic stress, secondary to arterial stiffening from hypertension or pressure overload, may also cause thickening of the walls of intramyocardial arterioles and localized inflammatory processes 46 leading to diffuse interstitial and focal fibrosis.
47,48
Methodological considerations
Our study demonstrates the relationship of myocardial fibrosis with prior CV events. MESA excluded from participation individuals with a previous history of clinical CV events. Therefore, extrapolation of our study results must be considered in the context of the study design and the population examined. Moreover, since our study did not include longitudinal measures of myocardial fibrosis, causal temporality cannot be determined. The methodological strength of this study is the performance of highly sophisticated measures in a large number of participants of a multi-ethnic population.
Conclusions
In conclusion, in a multi-ethnic free living population, having a CV event over the prior 10 years is associated with both a higher likelihood of focal myocardial fibrosis and increased diffuse interstitial fibrosis.
Supplementary data
Supplementary data are available at European Heart Journal -Cardiovascular Imaging online. All measurements in the below table were made at the Year-10 exam. All values are expressed as mean ± standard deviation, unless otherwise specified. AF, atrial fibrillation; All cardiovascular, CHD þ HF þ AF þ stroke þ PAD; AU, Agatston Units; CHD, coronary heart disease; HDL, high density lipoprotein; HF, heart failure; LV, left ventricle; PAD, peripheral arterial disease.
a In comparison to the group with no cardiovascular events.
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